Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-052127

President & CEO sold 83,333 shares at $21.54 ($1,794,993)

  • President & CEO acquired 83,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-09-06 Exercise or conversion : show line 1 in the form +83,333 $11.34 $944,996 235,837 D
2017-09-06 Sale : show line 2 in the form −83,333 $21.54 $1,794,993 152,504 D
Open-market sales · 83,333 sh · avg $21.54 · $1,794,993

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-09-06 Exercise or conversion : show line 3 in the form Stock Option −83,333 333,333 D
Loading xslF345X03/doc4.xml…